ISDA

Deposition Date 2018-08-23

Release Date 2019-07-03

Last Version Date 2024-01-17

Entry Detail

PDB ID:

6HGV

Keywords:

HYDROLASE

Title:

Soluble epoxide hydrolase in complex with talinolol

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21(DE3)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.20

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

I 2 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Bifunctional epoxide hydrolase 2
Gene (Uniprot):EPHX2
Chain IDs:A
Chain Length:346
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P34913 Pfam ID:PF00561 EC:3.1.3.106

Ligand Molecules

G3Q

Primary Citation

Computer-Aided Selective Optimization of Side Activities of Talinolol.

Hiesinger, K, Kramer, J.S, Achenbach, J, Moser, D, Weber, J, Wittmann, S.K, Morisseau, C, Angioni, C, Geisslinger, G, Kahnt, A.S, Kaiser, A, Proschak, A, Steinhilber, D, Pogoryelov, D, Wagner, K, Hammock, B.D, Proschak, E.Show

Acs Med.Chem.Lett. 10 899 903 (2019)

PMID: 31223445 DOI: 10.1021/acsmedchemlett.9b00075

Abstact

Selective optimization of side activities is a valuable source of novel lead structures in drug discovery. In this study, a computer-aided approach was used to deorphanize the pleiotropic cholesterol-lowering effects of the beta-blocker talinolol, which result from the inhibition of the enzyme soluble epoxide hydrolase (sEH). X-ray structure analysis of the sEH in complex with talinolol enables a straightforward optimization of inhibitory potency. The resulting lead structure exhibited in vivo activity in a rat model of diabetic neuropatic pain.

Legend

Protein

Chemical

Disease

Primary Citation of related structures